research use only

Sodium Pyruvate

Cat.No.E2902

Sodium Pyruvate (Sodium 2-oxopropanoate) is a compound produced in the glycolytic pathway. This compound is a free radical scavenger that can scavenge ROS.
Jump to

Quality Control

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 111.05 Formula

C3H4O3.Na

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 113-24-6 -- Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-08-07)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06037408 COMPLETED
Idiopathic Pulmonary Fibrosis
Cellular Sciences, inc.
2023-08-15 PHASE3
NCT04824365 COMPLETED
COVID-19
Cellular Sciences, inc.
2021-04-12 PHASE2; PHASE3
NCT04871815 COMPLETED
Long COVID
Cellular Sciences, inc.
2021-04-27 PHASE2; PHASE3
NCT04824365 Completed
COVID-19
Cellular Sciences inc.|Missouri State University|Dynamic DNA Labs|Trinity Health Care|Family First Medical Research Center
2021-04-12 Phase 2|Phase 3
NCT00308243 COMPLETED
Cystic Fibrosis
Emphycorp
2006-03 PHASE1
NCT00262652 TERMINATED
Moderate Asthma
Emphycorp
2006-01 PHASE1; PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.